Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

NCT03225248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Dyspepsia

Interventions

DRUG: UI05MSP015CT
DRUG: Gasmotin

Sponsor

Korea United Pharm. Inc.